BVT Aktienanleihe INN1 28.06.2024/ DE000VU9QN39 /
21/06/2024 19:43:40 | Var.-0.060 | Denaro19:43:40 | Lettera19:43:40 | Sottostante | Prezzo di esercizio | Expiration date | Tipo di opzione |
---|---|---|---|---|---|---|---|
99.950EUR | -0.06% | - Quantità in denaro: - |
- Quantità in lettera: - |
ING GROEP NV EO... | - EUR | 28/06/2024 | Call |
GlobeNewswire
08:00
First gene therapy for prevalent pathologies in neurology receives FDA IND clearance - EG 427 initi...
GlobeNewswire
07:30
PolTREG’s type-1 diabetes Treg cell therapy PTG-007 demonstrates long-term safety and efficacy for u...
GlobeNewswire
07:30
OSE Immunotherapeutics Announces Commercial and Revenue Sharing Agreement in the Field of CAR T-cell...
GlobeNewswire
07:00
Valneva Announces Health Canada Approval of the World’s First Chikungunya Vaccine, IXCHIQ®
GlobeNewswire
06:20
China's Hangzhou empowers urban development with world-class power supply reliability
GlobeNewswire
03:00
SALESFORCE ALERT: Bragar Eagel & Squire, P.C. is Investigating Salesforce, Inc. on Behalf of Salesfo...
GlobeNewswire
03:00
NIKE ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against...